ВОЗМОЖНОСТИ ПРИМЕНЕНИЯ МЕЛАТОНИНА В ЛЕЧЕНИИ БОЛЬНЫХ С ХИРУРГИЧЕСКИМИ ЗАБОЛЕВАНИЯМИ

мелатонин, хирургические болезни, предоперационный период, иммунологическая коррекция, интерлейкины

1. Зайцев О. С., Царенко С. В. Нейрореаниматология. Выход из комы (терапия посткоматозных состояний). М.: Литасс, 2012. 120 с.

2. Киселева А. В., Чурляев Ю. А., Григорьев Е. В. Роль оксида азота в повреждении нейронов при критических состояниях // Общая реаниматол. 2009. Т. 5. C. 80-83.

3. Мороз В. В., Бобринская И. Г., Васильев В. Ю. и др. Шок. М., 2011. С. 31.

4. Anto’n-Tay F., Diaz J. L., Fernandez-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications // Life Sci. 1971. Vol. 10. P. 841-850.

5. Btaiche I. F., Chan L. N., Pleva M., Kraft M. D. Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients // Nutr. Clin. Pract. 2010. Vol. 25. P. 32-49.

6. Buscemi N., Vandermeer B., Hooton N. et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis // Br. Med. J. 2006. Vol. 332. P. 385-393.

7. Carpentieri A., Dнaz de Barboza G., Areco V. et al. New perspectives in melatonin uses // Pharmacol. Res. 2012. Vol. 65. P. 437-444.

8. Carrillo-Vico A., Guerrero J. M., Lardone P.J., Reiter R. J. A re view of the multiple actions of melatonin on the immunesystem // Endocrine. 2005. Vol. 27. P. 189-200.

9. Caumo W., Levandovski R., Hidalgo M. P. Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study // J. Pain. 2009. Vol. 10. P. 100-108.

10. Di W. L., Kadva A., Johnston A., Silman R. Varying bioavailability of oral melatonin // N. Engl. J. Med. 1997. Vol. 336. P. 1028-1029.

11. Fruhwald S., Holzner P., Metzler H. Gastrointestial motilityin acute illness // Wien Klin. Wochenschr. 2008. Bd. 120. S. 1-2; 6-17.

12. Govitrapong P., Pariyanonth M., Ebadi M. The presence and actions of opioid receptors in bovine pineal gland // J. Pineal. Res. 1992. Vol. 13. P. 124-132.

13. Ionescu D., Badescu C., Ilie A., Acalovschi I. Melatonin as premedication for laparoscopic cholecystectomy A double- blind, placebo-controlled study: Scientific letter // SAJAA. 2008. Vol. 57. P. 8-11.

14. Jacobs M., Verdeja J. C., Goldstein H. S. Minimally invasive colon resection (laparoscopic colectomy) // Surg. Laparosc. Endosc. 1991. Vol. 1. P. 144-150.

15. Kucukakin B., Gogenur I., Reiter R. J., Rosenberg J. Oxidative stress in relation to surgery: is there a role for the antioxidant melatonin? // J. Surg. Res. 2009. Vol. 152. P. 338-347.

16. Leon J., Acuna-Castroviejo D., Escames G. et al. Melatonin mitigates mitochondrial malfunction // J. Pineal. Res. 2005. Vol. 38. P. 1-9.

17. Lissoni P., Rovelli F., Brivio F., Fumagalli L., Brera G. A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients // In Vivo. 2008. Vol. 22. P. 397-400.

18. Maestroni G. J. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer // Adv. Exp. Med. Biol. 1999. Vol. 467. P. 217-226.

19. Mcikova-Kalicka K.1, Bojkova B., Adamekova E. et al. Preventive effect of indomethacin and melatonin on 7, 12-dimethybenz/a/ anthracene-induced mammary carcinogenesis in female Sprague-Dawley rats. A preliminary report // Folia Biol. (Praha). 2001. Vol. 47. P. 75-79.

20. Naguib M., Samarkandi A., Moniem M. A. et al. Effects of melatonin premedication on propofol and thiopental induction dose-response curves: a prospective, randomized, double blind study // Anesth. Analg. 2006. Vol. 103. P. 1448-1452.

21. Nishimura S., Fujino Y., Shimaoka M. et al. Circadian secretion patterns of melatonin after major surgery // J. Pineal. Res. 1998. Vol. 25. P. 73-77.

22. Pandi-Perumal S. R., Srinivasan V., Maestroni G. J. et al. Melatonin: nature’s most versatile biological signal // FEBS J. 2006. Vol. 273. P. 2813-2838.

23. Pliss M. M., Pliss M. G. Enchancing recovery period in patients with colon cancer by melatonin preconditioning ERAS congress 2014 materials., Valencia, Spain. http: // www.eras.org

24. Reiter R. J., Tan D. X., Manchester L. C. et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions // Adv. Med. Sci. 2007. Vol. 52. P. 11-28.

25. Santoro R., Marani M., Blandino G. et al. Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation // Oncogene. 2012. Vol. 14. P. 2931-2942.

26. Shilo L., Dagan Y., Smorjik Y. et al. Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern // Am. J. Med. Sci. 1999. Vol. 317. P. 278-281.

27. Srinivasan V., Lauterbach E. C., Ho K. Y. et al. Melatonin in antinociception: its therapeutic applications // Curr. Neuropharmacol. 2012. Vol. 10. P. 167-178.

28. Vician M., Zeman M., Herichova I. et al. Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery // J. Pineal. Res. 1999. Vol. 27. P. 164-169.

29. Wilhelmsen M., Amirian I., Reiter R. J. et al. Analgesic effects of mela tonin: a review of current evidence from experimental and clinical studies // J. Pineal. Res. 2011. Vol. 51. P. 270-277.